Connection

Charles Greenberg to Heparin

This is a "connection" page, showing publications Charles Greenberg has written about Heparin.
Connection Strength

1.939
  1. Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 Jan; 45(1):130-134.
    View in: PubMed
    Score: 0.587
  2. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013 Jun; 116(6):1210-22.
    View in: PubMed
    Score: 0.419
  3. Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2019 Feb; 47(2):287-291.
    View in: PubMed
    Score: 0.158
  4. Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management. Anesthesiology. 1997 Sep; 87(3):667-75.
    View in: PubMed
    Score: 0.143
  5. Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit. Ann Clin Lab Sci. 2013; 43(4):429-35.
    View in: PubMed
    Score: 0.104
  6. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis. Thromb Haemost. 1992 Mar 02; 67(3):292-6.
    View in: PubMed
    Score: 0.098
  7. Limited proteolysis of vitronectin by plasmin destroys heparin binding activity. Thromb Haemost. 1991 Sep 02; 66(3):310-4.
    View in: PubMed
    Score: 0.095
  8. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery. J Thorac Cardiovasc Surg. 2005 Dec; 130(6):1567-72.
    View in: PubMed
    Score: 0.064
  9. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis. 2001 Mar; 12(2):85-93.
    View in: PubMed
    Score: 0.046
  10. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019 07; 157(1):34-43.e1.
    View in: PubMed
    Score: 0.040
  11. Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection. Arch Pathol Lab Med. 1998 Jan; 122(1):31-6.
    View in: PubMed
    Score: 0.037
  12. Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to monitor anticoagulation. Anesthesiology. 1997 Oct; 87(4):990-2.
    View in: PubMed
    Score: 0.036
  13. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem. 1994 Oct; 40(10):1962-9.
    View in: PubMed
    Score: 0.029
  14. Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. J Biol Chem. 1990 Feb 25; 265(6):3543-8.
    View in: PubMed
    Score: 0.021
  15. Production of a novel anticoagulant by neoplastic plasma cells: report of a case and review of the literature. Am J Med. 1989 May; 86(5):612-6.
    View in: PubMed
    Score: 0.020
  16. Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery. Ann Thorac Surg. 1987 Jun; 43(6):617-21.
    View in: PubMed
    Score: 0.018
  17. Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg. 1986 Nov; 4(5):522-8.
    View in: PubMed
    Score: 0.017
  18. Assessments of thrombogenicity by three in vitro techniques. Student Research Award in the Undergraduate, Master Candidate, or Health Science Degree Candidate Category, 21st annual meeting of the Society for Biomaterials, San Francisco, CA, March 18-22, 1995. J Biomed Mater Res. 1995 Sep; 29(9):1039-45.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.